Model‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients-Reference-Cited by-同舟云学术

Model‐Based Comparison of Dose‐Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis Patients

Published:2019-09-12 Issue:2 Volume:60 Page:198-208
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Suzuki Misaki¹,Shoji Satoshi¹,Miyoshi So¹,Krishnaswami Sriram²

Affiliation:

1. Prizer R&D Japan Tokyo Japan

2. Pfizer Inc. Groton Connecticut USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1514

Reference29 articles.

1. A quantitative analysis of kinase inhibitor selectivity

2. LiX JessonM LeeJ et al.Characterization of a potent inhibitor of JAK kinases CP‐690 550 and inhibition of specific JAK/lSTAT pathways at efficacious exposures in a rodent model of arthritis. Poster presented at:15th International Inflammation Research Association Conference; September 21‐24 2008; Chantilly Virginia.

3. Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes

4. Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

5. New insights into the regulation of T cells by γc family cytokines

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population;Biologics: Targets and Therapy;2022-07